The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
| Title | Creator | Relation Is Part Of | ||
|---|---|---|---|---|
| 1 |
 |
25-hydroxyvitamin D levels in optic neuritis and demyelinating disorders. Relation to paraclinical findings and demographic characteristics | Gorm Pihl-Jensen; Jette L. Frederiksen | NANOS 2014: Poster Presentations |
| 2 |
 |
A Multiple Sclerosis-Like Illness in a Man Harboring the LHOM 14484 Mutation | M. Tariq Bhatti, MD; N. J. Newman, MD | NANOS 1998: Poster Presentations (Session I) |
| 3 |
 |
Abnormal Electroretinogram findings in a patient with Neuromyelitis Optica Spectrum Disorder | Anjali Tannan; Aimee Szewka | NANOS 2014: Poster Presentations |
| 4 |
 |
Adding Vision Increases the Capacity of the Multiple Sclerosis Functional Composite (MSFC) to Identify Reductions in Neurological Impairment and Quality of Life | Sally Chia-Chien Chang; Dina Jacobs; Clyde Markowitz; Steven Galetta; Laura Balcer | NANOS 2008: Platform Session I |
| 5 |
 |
Adult Optic Neuritis (Abstract) | Christopher Glisson, DO, MS | NANOS 2019: How Do I Evaluate? Adult versus Kid: Does it Matter? |
| 6 |
 |
Adult Optic Neuritis (Slides) | Christopher Glisson, DO, MS | NANOS 2019: How Do I Evaluate? Adult versus Kid: Does it Matter? |
| 7 |
 |
Analysis of the Clinical Presentations of Optic Neuritis and (Presumed) Ischemic Optic Neuropathy: A Retrospective Study of 367 Patients | Joseph F. Rizzo III, MD | NANOS 1989: Scientific Platform Presentations (Session 2) |
| 8 |
 |
Asymptomatic Optic Neuritis in Neuromyelitis Optica and Multiple Sclerosis - a comparison | Su Ann Lim | NANOS 2014: Poster Presentations |
| 9 |
 |
Autoimmune Optic Neuritis - Masquerading as MS | Mark J. Kupersmith; Ronald M. Burde; Terence G. Klingele; Hal Mitnick; Floyd A. Warren | Scientific Platform Presentations (Session 1) |
| 10 |
 |
Axons and Ocular Symptoms in Multiple Sclerosis | Jane Sargent, MD | NANOS 1994: Clinical Presentations (Session II) |
| 11 |
 |
Binocular Summation of High- And Low-Contrast Visual Acuities in Multiple Sclerosis Patients Compared with Normal Humans | Matthew J. Thurtell; Janet C. Rucker; R. John Leigh | NANOS 2011: Poster Presentations |
| 12 |
 |
CHAMPS (the Controlled High Risk Avonex Multiple Sclerosis trial) Update | Steven L. Galetta, MD | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |
| 13 |
 |
Characterizing the Pathobiological Mechanisms of Binocular Acuity Summation versus Inhibition in MS: Central Adaptation or Not? | Sara S. Qureshi; Amy Conger; Darrel Conger; Ethan Meltzer; Peter Sguigna; Teresa Frohman; Elliot M. Frohman | NANOS 2014: Poster Presentations |
| 14 |
 |
Chronic Cerebrospinal Venous Insufficiency: A CSI Approach -- CSI of CCSVI | Norah S. Lincoff | NANOS 2012: Emerging Trends in Interventional Neuroradiology |
| 15 |
 |
Chronic Optic Neuritis | Terry A. Cox, MD, PhD | MRI vs. All Other Modalities in the Diagnosis of Multiple Sclerosis Symposium |
| 16 |
 |
Clinical Trials to Clinical Use: Using Vision as a Model for MS and Beyond | Laura J. Balcer | NANOS 2014: The Latest on OCT Symposium |
| 17 |
 |
Clinical Trials to Clinical Use: Using Vision as a Model for MS and Beyond | Laura J. Balcer | NANOS 2014: The Latest on OCT Symposium |
| 18 |
 |
Clinical Trials to Clinical Use: Using Vision as a Model for MS and Beyond - Case Study | Laura J. Balcer | NANOS 2014: The Latest on OCT Symposium |
| 19 |
 |
Comparing Retinal Nerve Fiber Layer Atrophy and Disability in Multiple Sclerosis | Fiona Costello; William Hodge; Irene Pan | NANOS 2009: Scientific Platform Presentations (Session II) |
| 20 |
 |
Comparing the Classic 2 Repetitions Per Second (2RPS) Visually Evoked Potential (VEP) with a New Metric using the Standard 60-Second Arc Check Size Driven by a Binary M-Sequence in a Group of Multiple Sclerosis Patients and Controls | Darrel Conger; Marlen and Mirna Lucero; Amy Conger; Shin Beh; Benjamin Frohman; Laura Balcer; Peter Calabresi; Elliot Frohman; Terea Frohman | NANOS 2014: Poster Presentations |
| 21 |
 |
The Comparison of Imaging of Optic Neuritis in Patients Diagnosed with Neuromyelitis Optica and Multiple Sclerosis | Sangeeta Khanna; Aseem Sharma; Robert Naismith; Gregory Van Stavern | NANOS 2011: Poster Presentations |
| 22 |
 |
Comparison of Macular Thickness/Volume and Retinal Nerve Fiber Layer Thickness among Patients with Relapsing-Remitting Multiple Sclerosis: Baseline Data from a Phase 3 Trial of Fingolimod | Kimberly Winges; Jack Werner; Danielle Harvey; Peter Calabresi; Laura Balcer; Kimberly Cello; Laurel Nelson; John Keltner | NANOS 2011: Scientific Platform Presentations (Session I) |
| 23 |
 |
Comparison of RNFL Measurements and Visual Function Among Patients with MS | Fiona Costello; William Hodge; Stuart Coupland; Eric Eggenberger; Mark Freedman; Randy Kardon | NANOS 2007: Scientific Platform Presentations (Session II) |
| 24 |
 |
Congruous Homonymous Sectoranopia in Multiple Sclerosis: an Atypical Cause of Lateral Geniculate Body Lesion | Mazen Choulakian; François Evoy | NANOS 2012: Poster Presentations |
| 25 |
 |
Contemporary and New Immunomodulatory Therapy for Multiple Sclerosis | Richard A. Rudick | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |